We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

67 hedge funds and large institutions have $34.7M invested in Checkpoint Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $1.1M | Put options by funds: $498K

31% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 16

7% more capital invested

Capital invested by funds: $32.3M → $34.7M (+$2.36M)

0.13% less ownership

Funds ownership: 1.52% → 1.4% (-0.13%)

3% less funds holding

Funds holding: 69 → 67 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

Holders
67
Holders Change
-2
Holders Change %
-2.9%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
21
Reduced
16
Closed
16
Calls
$1.1M
Puts
$498K
Net Calls
+$599K
Net Calls Change
+$427K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$425K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$405K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$347K
4
BlackRock
BlackRock
New York
+$332K
5
Two Sigma Investments
Two Sigma Investments
New York
+$297K

Top Sellers

Rank Fund Capital Flow
1
FWM
Frontier Wealth Management
Missouri
-$1.04M
2
ACM
ACT Capital Management
Pennsylvania
-$605K
3
Millennium Management
Millennium Management
New York
-$553K
4
E
Ergoteles
New York
-$466K
5
Marshall Wace
Marshall Wace
United Kingdom
-$398K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
76
Boothbay Fund Management
New York
– -$43K -1,463 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– -$39K -1,334 Closed
YIH
78
Y-Intercept (HK)
Hong Kong
– -$35K -1,197 Closed
Fisher Asset Management
79
Fisher Asset Management
Washington
– -$31K -1,050 Closed
PAM
80
Panagora Asset Management
Massachusetts
– -$16K -531 Closed
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
– -$1K -45 Closed
Group One Trading
82
Group One Trading
Illinois
– +$296 +10 New
1 2 3
4

CKPT Hedge Fund Activity: Q3 2021 in Review

67 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2021, worth a combined $34.7M — up 7.3% from $32.3M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of CKPT and 14 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 21 added.

The largest buyer was Vanguard Group, adding an estimated $425K. The largest seller was Frontier Wealth Management, exiting entirely with an estimated $1.04M sold.

  • 67 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2021, down from 69 in Q2 2021.
  • Funds reported $34.7M of Checkpoint Therapeutics stock for Q3 2021, up 7.3% quarter-over-quarter.
  • 14 funds opened new Checkpoint Therapeutics positions in Q3 2021 and 16 closed out, a net change of -2 holders.
  • The largest Checkpoint Therapeutics buyer in Q3 2021 was Vanguard Group, an estimated $425K added.
  • The largest Checkpoint Therapeutics seller in Q3 2021 was Frontier Wealth Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q3 2021.